12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Other News

NanoBio, Health Protection Agency (HPA), NIH infectious, drug delivery news

NIH's National Institute of Allergy and Infectious Disease (NIAID) awarded HPA a two year, £4 million ($6.4 million) contract to develop a next-generation anthrax vaccine. HPA will use NanoBio's NanoStat adjuvant technology to enable the vaccine to be delivered by fewer doses than currently required...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >